Scenario 3
Scenario Overview
This scenario is designed to test the calculator's capability to compute the parameters provided using the updated Singapore-modified Framingham Risk Score.
Based on the scenario, the patient should be stratified as a patient with intermediate cardiovascular risk.
Our calculator is embedded towards the end of the page to facilitate your testing.
Please help us improve by providing your feedback.
Click here to access the relevant ACE Clinical Guidances (ACGs).
Inputs to calculator
|
No. |
Question |
Parameter |
|---|---|---|
|
1 |
Gender |
Male |
|
2 |
AGE (years) |
55-59 |
|
3 |
ETHNICITY |
Malay |
|
4 |
SMOKER? |
Yes |
|
5 |
Patient’s HDL range - mmol/L (mg/dl) |
1.3-1.5 (50-59) |
|
6 |
Patient’s TC range - mmol/L (mg/dl) |
4.1-5.1 (160-199) |
|
7 |
Patient’s SYSTOLIC BP range - mmHg |
≥ 160 |
|
8 |
Patient on ANTIHYPERTENSIVES? |
Yes |
|
9 |
Patient history of ACS? |
No |
|
10 |
Patient history of ASCVD? |
No |
|
11 |
Patient have FH? |
No |
|
12 |
Patient have CKD? |
No |
|
13 |
Patient have DM? |
No |
Expected Results
Based on the above scenario, the patient will arrive at a risk score of 18%, according to the updated Singapore-modified Framingham Risk Score.
The following results will be provided by the calculator.
|
Segment |
Key Results |
|---|---|
|
Estimated 10-Year Coronary Artery Disease Risk: |
Intermediate risk (10 - 20%) |
|
Target LDL cholesterol: |
Consider LDL-C <2.6 mmol/L (<100mg/dL) |
|
Target Blood Pressure: |
<140/90 mmHg Consider going lower (e.g. <130/80 mmHg) as tolerated, especially if the patient has hypertension-mediated organ damage (HMOD). |
|
Target HbA1c: |
No target HbA1c recommendation, as patient does not have diabetes mellitus. |
Try it out!
Please feel free to try out the above scenario in the calculator below.
If you prefer to open up the calculator in a new window instead, please click the following link: https://for.sg/aegle-review